Datasheet is currently unavailable. Try again or CONTACT US
FGFA/FHFA (pan) Antibody Phycoerythrin
Mouse Monoclonal S235-22 IgG2b
200-308-W62
100 µg
Liquid (sterile filtered)
WB, IHC
Human, Mouse, Rat
Mouse
Shipping info:
$50.00 to US & $70.00 to Canada for most products. Final costs are calculated at checkout.
Product Details
Anti-FGFA/FHFA (pan) (MOUSE) Monoclonal Antibody Phycoerythrin Conjugated - 200-308-W62
Acidic fibroblast growth factor, AFGF, Beta endothelial cell growth factor, Fibroblast growth factor homologous factor 2A, Fibroblast growth factor 13A, FGF13A, Beta-endothelial cell growth factor, ECGF, ECGFA antibody, ECGFB, FHF-2, FHF2, FHF13, Fibroblast growth factor homologous factor 2, Fibroblast growth factor 13
Mouse
R-Phycoerythrin (RPE)
Monoclonal
IgG2b
Target Details
FGF13 - View All FGF13 Products
Human, Mouse, Rat
Conjugated Peptide
Anti-FGFA/FHFA (pan) Antibody was produced by repeated immunization of mice with a synthetic peptide containing amino acids 2-18 of human FHF2A.
Anti-FGFA/FHFA (pan) Antibody was purified from concentrated tissue culture supernate by Protein G chromatography. BLAST analysis suggests that it is 94% identical to mouse, 100% identical to rat and >80% identical to FGF12A/FHF1A, FGF14A/FHF4A, and FGF11A/FHF3A.
Application Details
IHC, WB
Anti-FGFA/FHFA (pan) R-PE Conjugated Antibody is tested for Western Blots, Immunohistochemistry and Immunocytochemistry. Expect a band approximately ~30 kDa on specific lysates or tissues. Does not cross react with FGF13B/FHF2B. Will cross react with FGF12A/FHF1A and FGF14A/FHF4A. Specific conditions for reactivity should be optimized by the end user.
Formulation
1mg/mL by UV absorbance at 280 nm
0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
0.1% (w/v) Sodium Azide
50% (v/v) Glycerol
Shipping & Handling
Wet Ice
Store vial at 4° C prior to opening. Dilute only prior to immediate use. This product is stable at 4° C as an undiluted liquid. Use subdued lighting during handling and incubation of cells prior to analysis. Store reagent in the dark. DO NOT FREEZE.
Expiration date is one (1) year from date of receipt.
FGF13(Fibroblast growth factor 13), also called FHF2 is a protein that in humans is encoded by the FGF13 gene. The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF13is a large gene, extending over approximately 200 kb in Xq26.3, and contains at least 7 exons. By cytogenetic, FISH, and database analysis, Gecz et al. (1999) localized the FGF13 gene within a 400-kb duplication interval on chromosome Xq26.3. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. Other areas of interests and use for researchers include cancer, borjeson-forssman-lehmann syndrome, regulation of actin cytoskeleton pathways, apoptosis, GPCR pathways, TGF-Beta pathways, and Rho family GTPase pathways.
This gene is located to a region associated with Borjeson-Forssman-Lehmann syndrome (BFLS), a syndromal X-linked mental retardation, which suggests it may be a candidate gene for familial cases of the BFL syndrome. The function of this gene has not yet been determined. Two alternatively spliced transcripts encoding different isoforms have been described for this gene.
This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.